Natera Inc Stock
Your prediction
Natera Inc Stock
We can see a decrease in the price for Natera Inc. Compared to yesterday it has lost -€4.000 (-2.030%).
Pros and Cons of Natera Inc in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Natera Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Natera Inc | -2.030% | -5.714% | 9.392% | 24.528% | 30.263% | 429.412% | - |
| Atricure Inc. | 2.960% | 4.819% | 24.286% | -43.871% | -43.871% | -43.871% | -11.224% |
| Orasure Tech | 1.870% | 2.830% | 2.830% | -43.229% | -36.257% | -55.328% | -79.434% |
| SI-BONE Inc | 0.630% | -5.917% | 2.581% | 22.308% | 22.308% | - | - |
News
Natera (NTRA) Q2 Revenue Jumps 32%
Natera (NASDAQ:NTRA), a leader in genetic testing across oncology, women's health, and organ health, reported its earnings for Q2 2025 on August 7, 2025. The most significant news was a 32.2%
